18/08/2021 01:09 PM | Click to read full article
Aspirin may help fight aggressive breast cancer by making hard-to-treat tumours more responsive to anti-cancer drugs, doctors say. A team at the Christie NHS Foundation Trust, in Manchester, are beginning a trial with triple-negative breast-cancer patients. They suspect it is aspirin's anti-inflammatory properties rather than its analgesic effect that gives the boost.
Trial lead Dr Anne Armstrong said: "Not all breast cancers respond well to immunotherapy. Trialling the use of a drug like aspirin is exciting because it is so widely available and inexpensive to produce. We hope our trial will show that, when combined with immunotherapy, aspirin can enhance its effects and may ultimately provide a safe new way to treat breast cancer."